ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1478

Construction and Validation of a Prediction Model of Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus

Bin Zhou1, QIn Huang2, Pan Wang3 and Qiguo Cui4, 1Nanfang Hospital, Guangzhou, Guangdong, China (People's Republic), 2Nanfang Hospital, Guangzhou, China (People's Republic), 3southern medical university Nanfang Hospital, Guangzhou, China (People's Republic), 4Southern Medical Univercity Nanfang Hospital, guang zhou, China (People's Republic)

Meeting: ACR Convergence 2025

Keywords: Cognitive dysfunction, risk factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1467–1516) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects multiple organs. Cognitive dysfunction (CD) is a common but often underestimated complication in SLE patients, seriously affecting their quality of life. The purpose of this study was to analyze the clinical data of SLE patients, screen effective predictors, and construct and validate a prediction model for the early identification of cognitive impairment in SLE patients.

Methods: The training cohort included 100 SLE patients. Baseline characteristics, clinical data, and laboratory and imaging data during hospitalization were screened using least absolute shrinkage and selection operator (LASSO) and logistic regression to construct a predictive risk score. The derived score represents an estimate of the risk of developing cognitive dysfunction in patients with SLE. A nomogram was constructed, and its accuracy and predictive performance were evaluated using the area under the receiver operating characteristic curve (AUC), calibration curves, and clinical decision curves. For the validation cohort, data were prospectively collected from 47 SLE patients.

Results: Six important predictors were screened out by LASSO regression: age, SDI, anxiety and depression, creatine kinase isoenzymes(CK-MB), triglycerides (TG), and anti-SSB antibodies, and a prediction model nomogram for SLE-CD was constructed. In the training cohort, the AUC of the model was 0.887 (critical value: 0.571, sensitivity: 0.821, specificity: 0.841, Youden index: 0.662). In the validation cohort, the AUC of the model was 0.877 (critical value: 0.526, sensitivity: 0.810, specificity: 0.846, Youden index: 0.656). The calibration curve showed that the predicted probability was highly consistent with the actual observed value, and the clinical decision curve suggested that the model had clinical application value within a wide range of thresholds.

Conclusion: The constructed SLE-CD prediction model showed good predictive efficacy in the training and validation cohorts and has potential clinical application value.

Supporting image 1Binomial deviance vs. log(λ) and Coefficient paths for different variables

Supporting image 2Nomogram for predicting cognitive impairment in SLE patients incorporating age, Anti-SSB,SDI,anxiety depression,TG and CK-MB.

Supporting image 3ROC curve for cognitive impairment prediction in the training cohort  (AUC: 0.887, cut-off value:0.571, sensitivity:0.821, specificity: 0.841, Youden index: 0.662) and validation cohort (AUC: 0.877, cut-off value: 0.526, sensitivity: 0.810, specificity: 0.846, Youden index: 0.656).


Disclosures: B. Zhou: None; Q. Huang: None; P. Wang: None; Q. Cui: None.

To cite this abstract in AMA style:

Zhou B, Huang Q, Wang P, Cui Q. Construction and Validation of a Prediction Model of Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/construction-and-validation-of-a-prediction-model-of-cognitive-dysfunction-in-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/construction-and-validation-of-a-prediction-model-of-cognitive-dysfunction-in-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology